Japanese researchers sought to build upon prior studies demonstrating the feasibility of liver resection in geriatric hepatocellular carcinoma patients, particularly in those undergoing major ...

Researchers assessed the prognostic significance of older age and comorbidity burden on overall survival in patients with hepatocellular carcinoma.

A cancer expert has shared the five types of cancer which are considered the most "lethal", and claimed people diagnosed with ...

Less than 20% of patients with FNH develop symptoms. Spontaneous rupture and ... the major issue is to distinguish FNH-like nodules from hepatocellular carcinoma (HCC). A mesenchymal hamartoma ...

vs percutaneous transhepatic biliary drainage (PTBD) for cholangiocarcinoma biliary obstruction: An updated systematic review and meta analysis. Baseline characteristics of patients with combined ...

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

A nurse, left "devastated" by her diagnosis, has bravely come forward ... However, Marissa faced further challenges when her liver cancer, known as hepatocellular carcinoma, recurred with a ...

Common symptoms of a liver tumor include ... Other types of liver cancer include hepatocellular carcinoma (a tumor grows on ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.

Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...